Slide 1: Nine Months 2021 Update
Nine Months 2021 Update November 2021
Slide 2: Disclaimer
Disclaimer This document may contain statement relevant to Azelis Group NV (the “Company”) and/or its affiliated companies (collectively “Azelis” or the “Azelis Group”) which are not historical facts and are hereby identified as “forward-looking statements”. Such forward looking statements, include,
Slide 3: Contents
Contents • Key developments & business update • Financial performance • Outlook • Q&A 3 © 2021 Azelis group. All rights reserved
Slide 4: Key developments Nine Months 2021
Key developments Nine Months 2021 4 © 2021 Azelis group. All rights reserved
Slide 5: Key developments 9M 2021
Key developments 9M 2021 Strong momentum YTD Solid cash generation Progress on initiatives Successful IPO • 20.7% total revenue • 43.7% FCF increase • Accelerated • Paid-down debt with growth despite ongoing investments in digital €823m net proceeds pressures on the strategy from IPO • 13.6% organic
Slide 6: Business update: Strong momentum in 9M 2021
Business update: Strong momentum in 9M 2021 Organic growth: 13.6% in 9M 2021 • Strong end-market demand • Industrial chemicals: Benefits from rebound in building & construction sector, in particular CASE • Life Sciences: Food & health starting to normalise to pre-Covid levels; Personal Care remains
Slide 7: Financial performance Nine Months 2021
Financial performance Nine Months 2021 7 © 2021 Azelis group. All rights reserved
Slide 8: Group P&L highlights 9M 2021
Group P&L highlights 9M 2021 CC1 Azelis Group Highlights 9M 2021 9M 2020 Change Change Revenue 2,038 1,689 21% 23% Life Sciences 1,260 1,049 20% 23% Industrial Chemicals 777 640 22% 24% Gross Profit 467 371 26% 30% Gross Profit Margin 22.9% 22.0% 93 bps Adjusted EBITA2 201 150 34% 37% Adjusted EBITA
Slide 9: Group Cash Flow and Balance Sheet highlights 9M 2021
Group Cash Flow and Balance Sheet highlights 9M 2021 Azelis Group Highlights 9M 2021 9M 2020 Change Operating profit 160 120 33% Amortization 28 25 Cashflows & Balance Sheet Adjustments 13 5 • Operational efficiencies reflected in higher Adjusted EBITA 201 150 34% profits Depreciation 14 12 • Workin
Slide 10: Regional financial update 9M 2021
Regional financial update 9M 2021 EMEA Americas Asia Pacific 45.0% € 1,000.0 52.6% 12.0% € 1,000.0 11.0% € 950.0 € 950.0 43.7% 10.6% 11.5% € 900.0 10.5% € 900.0 48.6% 11.8% € 500.0 8.0% 38.2% Adjusted EBITA Margin 11.0% Adjusted EBITA Margin Adjusted EBITA Margin € 450.0 € 850.0 € 850.0 7.5% 10.0% €
Slide 11: Outlook
Outlook 11 © 2021 Azelis group. All rights reserved
Slide 12: Outlook
Outlook Our strategy of driving growth is underpinned by a continually strengthening lateral value chain, supported by continuous investments in innovation capabilities and digitalization, as well as a commitment to sustainability to create long-term value. In line with this, we are positive that we
Slide 13: Q&A Contact Investor Relations
Q&A Contact Investor Relations investor-relations@azelis.com +32 (0) 478 51 23 89 13 © 2021 Azelis group. All rights reserved